期刊文献+

强化血糖控制与心血管疾病 被引量:2

Intensive glucose control and cardiovascular disease
原文传递
导出
摘要 心血管疾病作为糖尿病的最主要并发症已严重威胁人类健康。对糖尿病患者血糖的强化控制能否使心血管获益已成为目前研究的热点。通过对强化血糖控制与心血管疾病关系的研究,认为强化血糖控制与心血管获益之间的关系尚存在不确定性,需要更多循证医学研究支持。为平衡强化血糖控制的获益与风险,对糖尿病患者应早期采取积极、稳妥的个体化降糖策略,并应注重采取综合治疗方案。 Cardiovascular disease( CVD), as the most important complication of diabetes, has been a serious threat to human health. Whether intensive glucose control(IGC) in diabetic patients would bring the cardiovascular benefits has become a hotspot. The analysis about the relationship of IGC and CVD reveals that the relationship between the IGC and cardiovascular benefits is still uncertain. Further evidence-based medical researehes are needed, tn order to balance the benefits and risks of IGC, in clinical practice we should take an active, refiable and individual hypoglycemic strategies earlier for diabetic patients, and should pay attention to comprehensive treatment programs.
作者 王鹏 陈庆伟
出处 《国际内分泌代谢杂志》 2010年第5期324-327,共4页 International Journal of Endocrinology and Metabolism
关键词 强化血糖控制 心血管疾病 糖尿病 糖化血红蛋白A1C Intensive glucose control Cardiovascular diseases Diabetes melititus Haemoglobin A1c
  • 相关文献

参考文献21

  • 1Nissen SE,Tuzcu EM,Schoenhagen P,et al.Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis:A randomized controlled trial.JAMA,2004,291:1071-1080.
  • 2Colhoun HM,Betteridge DJ,Durrington PN,et al.Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS):Multicentre randomised placebo-controlled trial.Lancet,2004,364:685-696.
  • 3Bartnik M,Ryden L,Ferrari R,et al.The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe.The Euro Heart Survey on diabetes and the heart.Eur Heart J,2004,25:1880-1890.
  • 4中国心脏调查组,胡大一,潘长玉.中国住院冠心病患者糖代谢异常研究——中国心脏调查[J].中华内分泌代谢杂志,2006,22(1):7-10. 被引量:470
  • 5The Diabetes Control and Complications Trial Research Group.The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.N Engl J Med,1993,329:977-986.
  • 6de Boor IH,Kestenbaum B,Rue TC,et al.Insulin therapy,hyperglycemia,and hypertension in type 1 diabetes mellitus.Arch Intern Med,2008,168:1867-1873.
  • 7UK Prospective Diabetes Study (UKPDS) Group.Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).Lancet,1998,352:837-853.
  • 8Holman RR,Paul SK,Bethel MA,et al.l0-year follow-up of intensive glucose control in type 2 diabetes.N Engl J Med,2008,359:1577-1589.
  • 9Gerstein HC,Miller ME,Byington RP,et al.Effects of intensive glucose lowering in type 2 diabetes.N Engl J Med,2008,358:2545-2559.
  • 10Patel A,MacMahon S,Chalmers J,et al.Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.N Engl J Med,2008,358:2560-2572.

二级参考文献13

  • 1李素青,田玉华,朱敏,杨超元.中老年糖尿病流行病学调查方法探讨[J].实用老年医学,1996,10(4):175-176. 被引量:13
  • 2King H,Aubert RE,Herman WH.Global burden of diabetes 1995-2025.Prevalence,numerical estimates and projections.Diabetes Care,1998,21:1414-1431.
  • 3Bartnik M,Malmberg K,Hamsten A,et al.Abnormal glucose tolerance-a common risk factor in patients with acute myocardial infarction in comparison with population-based controls.J Int Med,2004,256:288-297.
  • 4Coutinho M,Gerstein HC,Wang Y,et al.The relationship between glucose and incident cardiovascular events:a metaregression analysis of published data from 20 studies of 95 783 individuals followed for 12.4years.Diabetes Care,1999,22:233-240.
  • 5The DECODE study group on behalf of the European Diabetes Epidemiology Group.Glucose tolerance and cardiovascular mortality.Arch Int Med,2001,161:397-404.
  • 6Bartnik M,Malmberg K,Norhammar A,et al.Newly detected abnormal glucose tolerance:an important predictor of long-term outcome after myocardial infarction.Eur Heart J,2004,25:1990-1997.
  • 7Norhammar A,Tenerz A,Nilsson G,et al.Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus:a prospective study.Lancet,2002,359:2140-2144.
  • 8Bartnik M,Ryden L,Ferrari R,et al.The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe:the Euro Heart Survey on diabetes and the heart.Eur Heart J,2004,25:1880-1890.
  • 9Hashimoto K,Ikewaki K,Yagi H,et al.Glucose intolerance is common in Japanese patients with acute coronary syndrome who were not previously diagnosed with diabetes.Diabetes Care,2005,28:1182-1186.
  • 10Choi KM,Lee KW,Kim SG,et al.Inflammation,insulin resistance,and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus.J Clin Endocrinol Metab,2005,90:175 -180.

共引文献496

同被引文献34

  • 1郭艺芳.冠心病患者血糖管理的新概念[J].中国医学前沿杂志(电子版),2009,1(1):1-3. 被引量:1
  • 2郝玉明,谢瑞芹.心血管病患者“强化降糖”新理念[J].中国医学前沿杂志(电子版),2009,1(1):20-23. 被引量:2
  • 3康慧,姜兆玲,张秀玲.糖化血红蛋白检测的临床意义[J].实用医技杂志,2006,13(14):2561-2562. 被引量:15
  • 4Kosiborod M, Rather S S, Inzucchi S E, et al. Adimission glucose and mortality in eldly patient hospitalized with acute myocardial infarction;implications for patients with and without recognized dia betes[J]. Circulation, 2005,111 : 3078- 3086.
  • 5Boucai L, Southern W N, Zonszein J. Hypoglycemia associated mortality is not drug-associated but linked to comorbidities[J]. Am J Med,2011,124(11):1028-1035.
  • 6Bouillet B, Vaillant G,Petit J M,et al. Are elderly patients with diabetes being overtreated in French long term-care homes? [J]. Diabetes Metab,2010,36(4):272- 277.
  • 7Aguilar D, Bozkurt B, Ramasubbu K, et al. Relationship of hemo globin AIC and mortality in heart failure patients with diabetes[J].J Am Coll Cardiol, 2009, 54(5) :422-428.
  • 8Gaede P, Lund- Andersen H, Parving H H, et al. Effect of a mul tifaetorial intervention on mortality in type 2 diabetes[J]. N Engl J Med, 2008, 358(6):580-591.
  • 9Bartnik M, Ryden L, Ferrari R, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: The Euro Heart Survey on diabetes and the heart[J]. Eur Heart J, 2004,25 (21) : 1880- 1890.
  • 10Califf R M, Holman R. Navigator Trial Steering Committee and investigators. People at increased risk of cardiovascular disease screened for the NAVIGATOR trial frequently have undiagnosed diabetes or impaired glucose tolerance[J]. J Am Coil Cardiol,2003, 41 (Suppl A) :530A- 531A.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部